Provided by Tiger Fintech (Singapore) Pte. Ltd.

Travere Therapeutics, Inc.

16.56
-1.3800-7.69%
Pre-market: 17.240.6800+4.11%04:12 EDT
Volume:3.23M
Turnover:54.05M
Market Cap:1.47B
PE:-4.06
High:17.26
Open:16.65
Low:15.99
Close:17.94
Loading ...

Travere Therapeutics Completes $143.8 Million Public Offering

MT Newswires Live
·
13 Nov 2024

Stock Track | Travere Therapeutics Plunges 8% After Pricing $125 Million Public Offering

Stock Track
·
08 Nov 2024

Travere Therapeutics Prices $125 Million Common Stock Offering

MT Newswires Live
·
08 Nov 2024

Travere Therapeutics prices $125M equity offering

seekingalpha
·
08 Nov 2024

BRIEF-Travere Therapeutics Prices Public Offering Of 7.81 Mln Shares At $16.00 Each

Reuters
·
08 Nov 2024

Travere Therapeutics Announces Pricing of Public Offering of Common Stock

THOMSON REUTERS
·
08 Nov 2024

Travere Therapeutics Inc - Prices Public Offering of 7.81 Mln Shares at $16.00 Each

THOMSON REUTERS
·
08 Nov 2024

Travere Therapeutics Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
08 Nov 2024

Travere Therapeutics (TVTX) Gets a Buy from TD Cowen

TIPRANKS
·
05 Nov 2024

Analysts Offer Insights on Healthcare Companies: Madrigal Pharmaceuticals (MDGL), Travere Therapeutics (TVTX) and Regeneron (REGN)

TIPRANKS
·
05 Nov 2024

Stifel Nicolaus Remains a Hold on Travere Therapeutics (TVTX)

TIPRANKS
·
05 Nov 2024

Stock Track | Travere Therapeutics Surges 5% Ahead of Investor Conferences

Stock Track
·
05 Nov 2024

Travere Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswire
·
05 Nov 2024

Travere Therapeutics Is Maintained at Overweight by Barclays

Dow Jones
·
01 Nov 2024

Travere Therapeutics (TVTX) Gets a Buy from Bank of America Securities

TIPRANKS
·
01 Nov 2024

Stock Track | Travere Therapeutics Surges 5% on Analyst Optimism Despite Mixed Earnings

Stock Track
·
01 Nov 2024

Travere Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
01 Nov 2024

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Takeda Pharmaceutical Company (TAK) and Voyager Therapeutics (VYGR)

TIPRANKS
·
01 Nov 2024

Travere Therapeutics (TVTX) Receives a Buy from Barclays

TIPRANKS
·
01 Nov 2024

Travere Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
01 Nov 2024